Bio Protocol vs Story — how do they compare? Bio Protocol trades at Rp439.92 (market cap Rp1T, Rp164,77M 24h volume), while Story trades at Rp5,692 (market cap Rp1,92T, Rp231,18M 24h volume). The key difference: Story is the larger of the two by market cap, and Bio Protocol's supply is capped (2,3B / 3,3B BIO (69%)) while Story's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Story for 24 Days on average.
| BIO | IP | |
|---|---|---|
Market Cap | Rp1T | Rp1,92T |
Volume (24h) | Rp164,77M | Rp231,18M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 356,6M IP |
Typical Hold Time | 18 Days | 24 Days |
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Story is a Layer 1 blockchain designed to serve as a foundation for intellectual property (IP) on the internet. It enables creators to register, license, and monetize their IP assets seamlessly. By leveraging blockchain technology, Story offers a transparent and efficient framework for IP attribution, licensing, and commercialization.
Read more on IP →